* If the product has intellectual property rights, a license granted is must or contact us.
Introduction of 10176-66-6 :
Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1 (hCE1) with an IC50 of 2.64 μM. Nevadensin has a variety of pharmacological effects such as anti-mycobacterium tuberculosis activities, antitussive, anti-inflammatory and anti-hypertensive. IC50 & Target: IC50: 2.64 μM (hCE1), 132.8 μM (hCE2)